Thomas Bogenrieder
Impact in
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Papers in
- Oncology 30
- Peptidase Inhibition and Analysis 6
- Cutaneous Melanoma Detection and Management 5
-
- Melanoma and MAPK Pathways 5
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Meenhard Herlyn (8 shared papers)Ulrike Weyer-Czernilofsky (7 shared papers)Kapaettu Satyamoorthy (3 shared papers)David E. Elder (1 shared paper)Dirk J. Ruiter (1 shared paper)Christos N. Papandreou (9 shared papers)Carola Berking (2 shared papers)Anthony P. Albino (9 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (5 papers)Oncogene (4 papers)Dermatology (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Thomas Bogenrieder
61 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 107
- Oncology 1.1k
- Immunology and Allergy 208
- Cancer Research 479
- Immunology 335
- Molecular Biology 1.1k
Countries citing papers authored by Thomas Bogenrieder
This map shows the geographic impact of Thomas Bogenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bogenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bogenrieder more than expected).
Fields of papers citing papers by Thomas Bogenrieder
This network shows the impact of papers produced by Thomas Bogenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bogenrieder. The network helps show where Thomas Bogenrieder may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Bogenrieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 495 | |
| 2 | 1998 | 245 | |
| 3 | 2016 | 200 | |
| 4 | 2002 | 193 | |
| 5 | 2003 | 142 | |
| 6 | 2002 | 140 | |
| 7 | 2017 | 128 | |
| 8 | 2010 | 81 | |
| 9 | 1997 | 80 | |
| 10 | 2003 | 73 | |
| 11 | 2018 | 69 | |
| 12 | 2001 | 65 | |
| 13 | Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. | 1996 | 63 |
| 14 | 2018 | 50 | |
| 15 | 2003 | 49 | |
| 16 | 1997 | 45 | |
| 17 | 2002 | 43 | |
| 18 | 2001 | 42 | |
| 19 | 2012 | 41 | |
| 20 | 2019 | 40 |
About Thomas Bogenrieder
Thomas Bogenrieder is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (7 papers), Immunotherapy and Immune Responses (6 papers), Peptidase Inhibition and Analysis (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (5 papers), Prostate Cancer Treatment and Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology and Allergy (208 citations), Cancer Research (479 citations), Immunology (335 citations) and Molecular Biology (1.1k citations). Thomas Bogenrieder has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Meenhard Herlyn, Ulrike Weyer-Czernilofsky, Kapaettu Satyamoorthy, David E. Elder, Dirk J. Ruiter, Christos N. Papandreou, Carola Berking, Anthony P. Albino, David M. Nanus and Valentine M. Macaulay. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, Oncogene and Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.